FUSION AND AMPLIFICATION OF 2 ORIGINALLY NONSYNTENIC CHROMOSOMAL REGIONS IN A MAMMARY-CARCINOMA CELL-LINE

被引:43
作者
LAFAGE, M
PEDEUTOUR, F
MARCHETTO, S
SIMONETTI, J
PROSPERI, MT
GAUDRAY, P
BIRNBAUM, D
机构
[1] INSERM, U119, MOLEC ONCOL LAB, 27 BD LEI ROURE, F-13009 MARSEILLE, FRANCE
[2] INSERM, U119, MOLEC HEMATOL & CYTOGENET LAB, F-13258 MARSEILLE 09, FRANCE
[3] INST J PAOLI I CALMETTES, CTR ANTICANCEREUX MARSEILLE, F-13009 MARSEILLE, FRANCE
[4] LGMCH, CNRS, URA 1462, NICE, FRANCE
[5] INST CURIE, F-75231 PARIS 05, FRANCE
关键词
D O I
10.1002/gcc.2870050107
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The FLG/FGFRI gene, encoding a receptor for members of the FGF family, is located at 8p11.2-p12. It is amplified, overexpressed, and not grossly rearranged in the MDA-MB-134 breast carcinoma cell line, whereas other genes from the pericentromeric 8p region are not amplified. The FGF4/HSTFI gene, located at 11q13, is also amplified with a substantial portion of the 11q13 region, but is not overexpressed in MDA-MB-134 cells. In this cell line, amplified sequences constitute a large homogeneously staining region (HSR) which is part of a marker chromosome containing chromosome 8 and chromosome 11 sequences. Using probes for the FGF4/HSTFI and the FLG/FGFRI genes in fluorescence chromosomal in situ hybridization, we show that the HSR contains de novo fused and amplified 11q13 and 8p 11-p12 sequences associated in a complex structure containing approximately the same number of FGF4 and FGFRI genes. The significance of this genetic abnormality for MDA-MB-134 cells, and for breast carcinogenesis in general, is unknown, but may underlie a particular type of oncogene activation.
引用
收藏
页码:40 / 49
页数:10
相关论文
共 51 条
  • [1] ADELAIDE J, 1988, ONCOGENE, V2, P413
  • [2] ADNANE J, 1991, ONCOGENE, V6, P659
  • [3] LOCALIZATION OF THE FIBROBLAST GROWTH-FACTOR RECEPTOR-4 GENE TO CHROMOSOME REGION 5Q33-QTER
    ARMSTRONG, E
    PARTANEN, J
    CANNIZZARO, L
    HUEBNER, K
    ALITALO, K
    [J]. GENES CHROMOSOMES & CANCER, 1992, 4 (01) : 94 - 98
  • [4] MOLECULAR THEMES IN ONCOGENESIS
    BISHOP, JM
    [J]. CELL, 1991, 64 (02) : 235 - 248
  • [5] BREAST TUMOR-CELL LINES FROM PLEURAL EFFUSIONS
    CAILLEAU, R
    YOUNG, R
    OLIVE, M
    REEVES, WJ
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) : 661 - 674
  • [6] CHARACTERIZATION AND CHROMOSOME ASSIGNMENT OF THE HUMAN HOMOLOG OF INT-2, A POTENTIAL PROTOONCOGENE
    CASEY, G
    SMITH, R
    MCGILLIVRAY, D
    PETERS, G
    DICKSON, C
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 1986, 6 (02) : 502 - 510
  • [7] GENOMIC SEQUENCING
    CHURCH, GM
    GILBERT, W
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (07): : 1991 - 1995
  • [8] DEVILEE P, 1990, CANCER SURV, V9, P605
  • [9] CLONING AND EXPRESSION OF 2 DISTINCT HIGH-AFFINITY RECEPTORS CROSS-REACTING WITH ACIDIC AND BASIC FIBROBLAST GROWTH-FACTORS
    DIONNE, CA
    CRUMLEY, G
    BELLOT, F
    KAPLOW, JM
    SEARFOSS, G
    RUTA, M
    BURGESS, WH
    JAYE, M
    SCHLESSINGER, J
    [J]. EMBO JOURNAL, 1990, 9 (09) : 2685 - 2692
  • [10] CHARACTERIZATION OF CHROMOSOMAL-ANOMALIES IN HUMAN BREAST-CANCER - A COMPARISON OF 30 PARADIPLOID CASES WITH FEW CHROMOSOME CHANGES
    DUTRILLAUX, B
    GERBAULTSEUREAU, M
    ZAFRANI, B
    [J]. CANCER GENETICS AND CYTOGENETICS, 1990, 49 (02) : 203 - 217